Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Nvidia Develops New Location-Verification Technology for AI Chips 
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies 
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
CVS Health Signals Strong 2026 Profit Outlook Amid Turnaround Progress 
Westpac Director Peter Nash Avoids Major Investor Backlash Amid ASX Scrutiny 
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market 
REDWOOD CITY, Calif., March 02, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2016 financial results after market close on Thursday, March 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
| Live Call: | U.S. | 855 890 8665 |
| International | 720 634 2938 | |
| Passcode | 77904180 | |
| Live Webcast: | Codexis IR Website | |
| The webcast will be archived for 30 days. | ||
| Replay: | U.S. | 855 859 2056 |
| International | 404 537 3406 | |
| Passcode | 77904180 | |
| The replay will be available for 48 hours | ||
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
CONTACTS:
Investors
LHA
Jody Cain, 310 691 7100
[email protected]
Media
That’s Nice
Guy Tiene, 212 366 4455
[email protected]
